NATURES SUNSHINE PRODUCTS INC - Common Stock (NATR)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NATR on Nasdaq
CUSIP
639027101
Type / Class
Equity / Common Stock
Shares outstanding
17.7M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
14.3M
Holdings value
$211M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
114
Number of buys
78
Number of sells
-25
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NATURES SUNSHINE PRODUCTS INC - Common Stock (NATR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DIMENSIONAL FUND ADVISORS LP 5.2% $14.2M 914K Dimensional Fund Advisors LP Sep 30, 2025
BlackRock, Inc. 5.04% $13.8M 890K BlackRock, Inc. Sep 30, 2025
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 0.35% -97.2% $735K -$32.7M 64.2K -97.8% Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Jun 25, 2025

Institutional Holders of NATURES SUNSHINE PRODUCTS INC - Common Stock (NATR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 133K $2.06M +$82.7K $15.52 10
2025 Q2 14.3M $211M -$12.7M $14.79 114
2025 Q1 15.2M $191M -$1.16M $12.55 95
2024 Q4 15.3M $224M -$520K $14.66 92
2024 Q3 15.3M $209M +$4.46M $13.62 88
2024 Q2 15M $226M -$3.09M $15.07 98
2024 Q1 15M $310M +$2.73M $20.77 106
2023 Q4 28.7K $495K +$122K $17.29 2
2023 Q3 14.4M $238M -$1.89M $16.57 90
2023 Q2 14.5M $197M +$39.3K $13.65 79
2023 Q1 11.6M $118M +$2.74M $10.21 76
2022 Q4 14.3M $119M -$280K $8.32 79
2022 Q3 14.4M $118M -$807K $8.24 73
2022 Q2 14.4M $153M -$110K $10.67 75
2022 Q1 14.2M $240M -$1.93M $16.82 91
2021 Q4 14.3M $265M +$2.25M $18.50 89
2021 Q3 14.3M $210M +$11.1M $14.65 78
2021 Q2 13.5M $235M -$5.63M $17.37 74
2021 Q1 12.5M $250M +$2.68M $19.96 72
2020 Q4 13.1M $196M +$814K $14.95 64
2020 Q3 14.9M $173M +$3.16M $11.57 66
2020 Q2 15.1M $136M +$180K $9.01 63
2020 Q1 15.1M $123M +$1.17M $8.13 57
2019 Q4 15M $134M +$1.58M $8.93 56
2019 Q3 14.7M $122M +$1.9M $8.29 56
2019 Q2 14.6M $136M +$1.03M $9.29 53
2019 Q1 14.5M $135M -$4.4K $9.29 51
2018 Q4 14.5M $118M -$26.6K $8.15 52
2018 Q3 14.5M $127M -$267K $8.75 53
2018 Q2 14.5M $136M -$44.7K $9.35 50
2018 Q1 14.5M $160M +$1.28M $11.00 51
2017 Q4 14.4M $166M +$1.24M $11.55 51
2017 Q3 14.2M $144M +$852K $10.15 54
2017 Q2 14.1M $187M +$2.19M $13.25 55
2017 Q1 14M $140M +$3.73M $10.00 52
2016 Q4 14M $210M +$1.54M $15.00 59
2016 Q3 13.8M $222M +$1.62M $16.00 57
2016 Q2 13.8M $131M -$165K $9.53 54
2016 Q1 13.8M $132M -$1.04M $9.60 52
2015 Q4 13.9M $140M +$246K $10.12 49
2015 Q3 13.8M $166M -$135K $11.98 56
2015 Q2 13.7M $189M -$1.53M $13.75 58
2015 Q1 14M $184M -$1.21M $13.12 63
2014 Q4 14.1M $208M +$40.5M $14.82 64
2014 Q3 11.3M $167M -$4.48M $14.83 64
2014 Q2 11.5M $196M +$813K $16.97 67
2014 Q1 11.5M $159M +$1.18M $13.78 64